ClinicalTrials.Veeva

Menu
D

Diabetes and Glandular Disease Clinic, P.A. | San Antonio, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

PF-05221304
K-877-ER
Firsocostat
PF-06865571
CSG452
Cilofexor
TVB-2640

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (SUNRISE)

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

INHALE-3 is a Phase 4, randomized controlled trial (RCT) that will randomly assign participants ≥18 years of age with type 1 diabetes (T1D) using mul...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: Afrezza
Biological: Basal Insulin

The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump

The goals of this clinical study are to learn more about the study drugs, semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firso...

Active, not recruiting
Nonalcoholic Steatohepatitis
Drug: PTM CILO/FIR
Drug: Cilofexor (CILO)/Firsocostat (FIR)

A study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatoh...

Enrolling
NASH
Drug: Placebo
Drug: K-877-ER

Trial sponsors

D
Medtronic logo
Gilead Sciences logo
Kowa logo
MannKind logo
Pfizer logo
S
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems